Verquvo 2.5 mg, Filmtabletten - 14 Swissmedic Key 68001001 Registration Holder Bayer (Schweiz) AG Name Verquvo 2.5 mg, Filmtabletten Date of registration 22.09.2021 Introduction of Sequence 22.09.2021 ATC-Classification Vericiguat (C01DX22) Revision date WHO WHO-DDD Valid until 21.09.2026 Index Therapeuticus (BSV) 02.99. Show package size 14 Index Therapeuticus (Swissmedic) 02.07.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 34.89 Limitation Yes Limitation text
Deductible 10 % Consumer price 54.35 Feedback FB Daily cost GTIN 7680680010013 Medication Code Synthetika Pharmacode Disponibility
Composition Filmtablette: vericiguatum 2.50 mg, cellulosum microcristallinum, carmellosum natricum conexum, hypromellosum, lactosum monohydricum 61.20 mg, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, talcum, E 171, pro compresso obducto corresp. natrium 0.80 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose additional_information Vericiguatum 2.5 mg Filmtablette
BAG: Active Agent Dose Vericiguatum 2.5 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Hypromellosum Überzug Lactose Monohydrate 61.2 mg Magnesii Stearas Natrii Laurilsulfas Pro Compresso Obducto Talcum
Source Data was imported : 06.10.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
